Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? EQUITY AND STOCK-BASED COMPENSATION - Narrative (Details)

v3.22.2.2
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION - Narrative (Details)
 1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2022
USD ($)
shares
Jun. 30, 2022
USD ($)
shares
May 31, 2022
USD ($)
shares
Apr. 30, 2022
shares
Mar. 31, 2022
USD ($)
shares
Feb. 28, 2022
USD ($)
shares
Sep. 30, 2022
USD ($)
vendor
$ / shares
shares
Jun. 30, 2022
USD ($)
shares
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
$ / shares
shares
Sep. 30, 2021
USD ($)
shares
Mar. 31, 2021
$ / shares
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Debt instrument converted, shares issued (in shares)                   12,542,126 12,542,126  
Debt instrument, face amount | $             $ 8,800,000     $ 8,800,000    
Common stock issued as payment of fees (in shares)             531,393          
Number of vendors | vendor             1          
Value of stock issued for services | $             $ 361,000          
Grant date fair value of subscriptions for common stock | $                   $ 41,000    
Grant date fair value of shares | $ $ 80                   $ 0  
Warrants to purchase common stock (in shares)       750,000     23,951,571     23,951,571    
Exercise price of warrants (in dollars per share) | $ / shares             $ 0.85     $ 0.85   $ 1.087
Exercise of stock options (in shares) 45,000 312,248       10,000       40,081,173    
Increase in exercise price of options (in dollars per share) | $ / shares                   $ 0.91    
Remaining average life of options (in years)                   3 years    
Proceeds from exercise of stock options | $ $ 7,100         $ 3,000       $ 10,000 31,000  
Shares issued in period, options (in shares)               200,000        
Stock based compensation | $             $ 1,400,000   $ 5,600,000 $ 6,400,000 $ 7,200,000  
$8.8 million Promissory Note                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Debt instrument converted, shares issued (in shares)                   1,142,858    
Share-Based Payment Arrangement, Option                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Shares withheld for withholding obligations (in shares)   112,248                    
Common stock                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Debt instrument converted, shares issued (in shares)                   1,142,858    
Common stock issued as payment of fees (in shares)                   906,393 409,308  
Issuance of common stock to employee (in shares) 139                   11,413  
Restricted stock issued (in shares)   4,221     375,000     2,717        
Grant date fair value of restricted stock issued | $   $ 2,500     $ 274,000     $ 2,000        
Common stock withheld in exercise of warrants (in shares)       515,039                
Cashless exercise of warrants (in shares)       234,961                
Exercise of stock options (in shares)                   55,000 178,885  
Common stock | Chief Financial Officer                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Restricted stock issued (in shares)     350,000                  
Grant date fair value of restricted stock issued | $     $ 217,000                  
Common stock subscribed but not issued                        
Accumulated Other Comprehensive Income (Loss) [Line Items]                        
Subscriptions for common stock (in shares)             74,581     74,581    
Grant date fair value of subscriptions for common stock | $             $ 41,000     $ 41,000    
Issuance of common stock to employee (in shares)                     (11,413)  
Grant date fair value of shares | $                     $ (5,000)